Innovation in Gastroenterology

Movetis is a rapidly growing European specialty pharmaceutical company focused on the discovery, development and commercialisation of novel innovative drugs for the treatment of gastrointestinal diseases with high unmet need.

Movetis aims to become a European successful specialty GI company by developing its own commercial infrastructure in selected EU markets and by working with partners to enable its products to benefit GI patients globally.